OMNI BIO PHARMACEUTICAL, INC. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c1732751-b1d4-444d-8278-1ddef5aca510/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $-38.3M | 2006-02-28 – 2014-03-31 | evidence 0001437749-14-011253 |
| FY 2012 | $-36.4M | 2006-02-28 – 2013-03-31 | evidence 0001437749-13-008162 |
| FY 2011 | $-4.6M | 2011-04-01 – 2012-03-31 | evidence 0001437749-12-006846 |
| FY 2010 | $-8.2M | 2010-04-01 – 2011-03-31 | evidence 0001437749-12-006846 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).